Stoke Therapeutics与渤健公司在2025年美国癫痫学会年会上展示进一步支持Zorevunersen作为Dravet综合症治疗药物的疾病改变潜力的数据
Stoke Therapeutics与渤健公司在2025年美国癫痫学会年会上展示进一步支持Zorevunersen作为Dravet综合症治疗药物的疾病改变潜力的数据
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.